| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |